Skip to content

Should Colorectal Cancer screening be done in India?

Should Colorectal Cancer screening be done in Asymptomatic Indians: A Pan-India multicentre study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/03/063839
Enrollment
6500
Registered
2024-03-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NA: NA Control Intervention1: NA: NA

Sponsors

Indian Council of Medical Research (ICMR)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy asymptomatic adults aged between 50-75 years.(Absence of following symptoms: weight loss, persistent fever, anaemia, diarrhoea, rectal bleeding, constipation (recent onset within past 1 year), persistent abdominal pain). 2. Written Informed consent.

Exclusion criteria

Exclusion criteria: 1.Prior diagnosis of cancer 2.Family history of CRC: those with recognised familial genetic syndromes;those having FDRs with documented advanced adenomas. 3.Inflammatory Bowel Disease 4.Colonoscopy, gFOBT,FIT, sigmoidoscopy, barium enema done within the last 10 years 5.Recent onset of lower gastrointestinal tract symptoms (bleeding, change in bowel habit, abdominal pain, weight loss, bloating, anaemia) causing healthcare attendance in the previous 12 months. 6.Significant comorbidity (American Society of Anaesthesiologists class III or greater) 7.Previous gastrointestinal surgery 8.Participation in any other clinical trial in the previous 3 months 9.A person unlikely to be compliant or unable to give informed consent

Design outcomes

Primary

MeasureTime frame
To evaluate the prevalence of advanced colorectal neoplasia or colorectal cancer in asymptomatic healthy adults aged 50-75 years by adopting a modified risk score based screening strategy in India.Timepoint: Baseline, Follow up 1st year, Follow up 2nd year

Secondary

MeasureTime frame
To evaluate the cost effectiveness or benefit of adopting a risk score based screening strategy.Timepoint: Baseline, Follow up 1st year, Follow up 2nd year;To evaluate the prevalence of all forms of colorectal polyps in asymptomatic healthy adults.Timepoint: Baseline, Follow up 1st year, Follow up 2nd year;To identify the contribution of each risk factor for occurrence of advanced colorectal neoplasia or colorectal cancer.Timepoint: Baseline, Follow up 1st year, Follow up 2nd year

Countries

India

Contacts

Public ContactDr Vineet Ahuja

All India Institute of Medical Sciences, Delhi

vineet.aiims@gmail.com9810707170

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026